| Product NDC: | 10544-591 |
| Proprietary Name: | OxyContin |
| Non Proprietary Name: | oxycodone hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; oxycodone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10544-591 |
| Labeler Name: | Blenheim Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020553 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100126 |
| Package NDC: | 10544-591-20 |
| Package Description: | 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10544-591-20) |
| NDC Code | 10544-591-20 |
| Proprietary Name | OxyContin |
| Package Description | 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10544-591-20) |
| Product NDC | 10544-591 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxycodone hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100126 |
| Marketing Category Name | NDA |
| Labeler Name | Blenheim Pharmacal, Inc. |
| Substance Name | OXYCODONE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |